IOVA Chart
- 52-Week Range: $12.32 - $27.63
- Market Capitalization: $2.36B
- Short Percentage: 0%
- Target Price: $35.46
- Shares Outstanding: 157.17M
- Next Earnings: Nov 30
Catalysts
CategoryCatalyst
Earnings
IOVA released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.
News and Press Releases
- Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)GlobeNewsWire | May 20th
- Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)GlobeNewsWire | April 22nd
- Iovance Biotherapeutics Announces Regulatory and Clinical Updates for Lifileucel in MelanomaGlobeNewsWire | April 5th
- Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)GlobeNewsWire | March 15th
- Iovance Biotherapeutics' (IOVA) CEO Fred Vogt on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha | February 24th
- Iovance Biotherapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Corporate UpdatesGlobeNewsWire | February 24th
- Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)GlobeNewsWire | February 18th
Company Info
Website: https://www.iovance.com
Address: 825 Industrial Road, San Carlos, CA, United States, 94070
Sector: Healthcare
Industry: Biotechnology
Full time employees: 319
Address: 825 Industrial Road, San Carlos, CA, United States, 94070
Sector: Healthcare
Industry: Biotechnology
Full time employees: 319
$IOVA is going to have a run next month
$IOVA is it Monday yet???
$IOVA YALL READY????????
$IOVA might get a sell off today
$IOVA im in.
$IOVA this sell-off is meh.
$IOVA about to pop IMHO
$IOVA going green
$IOVA I would not be a bear now
$IOVA breaking out of this wedge sooner than later